Investigating urinary tract infections caused by resistant bacteria in women
Community-onset urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in women of diverse backgrounds
This study is looking at urinary tract infections (UTIs) caused by a specific type of bacteria in women from different backgrounds to find out what factors might increase the risk of these infections and how to prevent them better.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10992196 on NIH RePORTER |
What this research studies
This research focuses on understanding community-onset urinary tract infections (UTIs) caused by extended-spectrum beta-lactamase-producing Escherichia coli in women from diverse backgrounds. The study aims to identify demographic and neighborhood-level risk factors associated with these infections, as well as complications and trends in prevalence. By combining epidemiological methods, the research seeks to uncover novel risk factors that could be targeted for prevention and improved outcomes. The project is led by Dr. Eva Raphael, who is receiving training to enhance her skills as a clinician-researcher in this field.
Who could benefit from this research
Good fit: Ideal candidates for this research are women experiencing community-onset urinary tract infections, particularly those from diverse backgrounds.
Not a fit: Patients who do not have urinary tract infections or those who are not women may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better prevention strategies and treatment options for women suffering from antibiotic-resistant urinary tract infections.
How similar studies have performed: Previous research has shown success in identifying risk factors for infections caused by antibiotic-resistant bacteria, indicating that this approach has potential for meaningful findings.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Raphael, Eva — University of California, San Francisco
- Study coordinator: Raphael, Eva
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.